Show Summary Details
Page of

The Antioxidant Debate 

The Antioxidant Debate
The Antioxidant Debate

Elena J. Ladas

and Kara M. Kelly

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 September 2020

Chapter 10 cover the antioxidant debate, including the use of antioxidant supplements in combination with conventional chemotherapy and radiotherapy to enhance the anticancer activity and to reduce the side effects of conventional treatment, that while some evidence suggests that antioxidants may be beneficial (e.g., enhancing survival, reducing toxicity), other evidence suggests that antioxidants may reduce the efficacy of cancer therapy, that not all chemotherapy agents rely on oxidative stress for anticancer activity, how several studies have shown that plasma concentrations of antioxidants are depleted in individuals undergoing treatment for cancer and that this decrease may be associated with therapy-related toxicities, how the role of antioxidants for the treatment of cancer remains unclear, that the efficacy of antioxidants as part of a supportive care regimen is limited, how the use of ?-carotene and vitamin E supplements in conjunction with radiation therapy is contraindicated and should be avoided, especially among smokers, and that, while the results from clinical trials for some antioxidants appear to be encouraging, health-care providers should be cautious about recommending antioxidant supplements during chemotherapy until adequately powered clinical studies are available to guide clinical practice.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.